Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for prevention of postoperative delirium after cardiac surgery
ACTRN12615000819527Phase 3Completed
- Sponsor
- The University of Western Australia
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of melatonin in delirium, sponsored by The University of Western Australia. Primary endpoint: Incidence of postoperative delirium. Started Feb 2016; status: completed.
02
Drugs
melatonin
03
Conditions
delirium
Beyond the preview
Go deeper on ACTRN12615000819527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000819527.